SCHEMBL24590616

SCHEMBL24590616

O=CN1CCN(Cc2ccc(C(=O)NCC(=O)c3ccccc3)cc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 4/20 0.56
▸ HDAC4 P56524 3/20 0.56
▸ KCNH2 Q12809 2/20 0.56
▸ ALDH1A1 P00352 3/20 0.52
▸ CCR2 P41597 2/20 0.51
▸ NPC1 O15118 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ ACHE P22303 1/20 0.49
▸ HIF1A Q16665 2/20 0.47
▸ EPAS1 Q99814 2/20 0.47
▸ HDAC6 Q9UBN7 2/20 0.47
▸ HDAC3 O15379 1/20 0.47
▸ HDAC7 Q8WUI4 1/20 0.47
▸ HDAC2 Q92769 1/20 0.47
▸ HDAC10 Q969S8 1/20 0.47
▸ HDAC11 Q96DB2 1/20 0.47
▸ HDAC8 Q9BY41 1/20 0.47
▸ HDAC9 Q9UKV0 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23014409 0.84 ALDH1A1 (0.73) HDAC1ALDH1A1NPC1RAB9AKMT2A
SCHEMBL23014159 0.81 ALDH1A1 (0.57) HDAC1HDAC4KCNH2ALDH1A1MEN1
SCHEMBL23014311 0.81 L3MBTL1 (0.53) HDAC1HDAC4KCNH2ALDH1A1NPC1
SCHEMBL23014510 0.81 P2RY12 (0.53) HDAC1HDAC4KCNH2ALDH1A1KMT2A
SCHEMBL23014235 0.80 HTR1A (0.58) HDAC1HDAC4KCNH2NPC1RAB9A
SCHEMBL23014236 0.79 KDM4E (0.56) HDAC1HDAC4KCNH2ALDH1A1CCR2
SCHEMBL30388111 0.79 SMN1; SMN2 (0.69) HDAC1ALDH1A1RAB9AMEN1KMT2A
SCHEMBL23014335 0.79 SMN1; SMN2 (0.69) HDAC1ALDH1A1RAB9AMEN1KMT2A
SCHEMBL29275413 0.79 HDAC4 (0.55) HDAC1HDAC4KCNH2ALDH1A1HDAC6
SCHEMBL23014404 0.78 MBTD1 (0.58) HDAC1HDAC4KCNH2CCR2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4019495-A1 NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND Cellgentek Co., Ltd (KR) 2022-06-29 — — EP disclosed
Send feedback